Home Page
|
Company
Company Profile
Management
Board of Directors
Scientific Advisory Board
Contact Us
|
Technology
Background
The Cell Enrichment Process
Intellectual Property
|
Products
|
Applications
CEP Separation System
Prenatal Testing
Stem Cells
Cancer Metastasis
|
Investor Relations
Investment Opportunity
|
FAQS
|
Home Page
The CEP Advantage
News and Media
Site Map
Contact Us
News
BioCep raises $525K from its investors
Prof. Max Herzberg joins BioCep's board of directors
BioCep raises $525K from Angel Investors
BioCep chosen to represent Israel at the Medventures event in France
BioCep closes 2 million NIS round
Professor Dian Donnai joins BioCep's scientific advisory board
BioCep appoints Doron Birger, former CEO at Elron as the Chairman of its board
CEP has been validated by a leading lab and found to be significantly more effective than current separation solutions.
Site Search
Search
Home
>> Technology
Technology
LiveCity - Website Builder
